期刊文献+

雷贝拉唑预防心血管病患者阿司匹林引起的消化性溃疡 被引量:11

Rabeprazole for preventing aspirin-related peptic ulcer in patients with cardiovascular diseases
下载PDF
导出
摘要 目的探讨雷贝拉唑对小剂量阿司匹林引起消化性溃疡的预防作用。方法纳入2010年6月~2012年2月,患心血管病需抗血小板治疗的患者166例,随机分为对照组(n=83)和观察组(n=83)。对照组单用阿司匹林(100mg,qd);观察组在服用等剂量阿司匹林肠溶片同时服用雷贝拉唑钠肠溶胶囊(20mg,qd)。对比两组患者出现上腹不适、上腹痛、烧心、反酸等消化道不适症状,同时比较两组胃镜下黏膜表现变化和呕血、黑便等消化道出血临床症状。结果对照组和观察组分别出现消化道症状37例(44.6%)和4例(4.8%),对照组胃肠黏膜损伤患者29例(34.9%),其中消化性溃疡12例(14.5%),观察组发生胃黏膜损伤患者仅6例(7.2%),其中消化性溃疡1例(1.2%),观察组的消化道症状发生率、胃肠粘膜损伤率以及消化性溃疡发生率均显著低于对照组,差异均有统计学意义(P均<0.05)。随访3个月和6个月时患者呕血、黑便等消化道出血情况观察组均小于对照组,差异有统计学意义(P<0.05)。结论雷贝拉唑钠肠溶可降低小剂量阿司匹林治疗中发生溃疡出血的风险。 Objective To investigate the preventive effect of rabeprazole on peptic ulcer induced by low- dose aspirin. Methods The patients (n=166) with cardiovascular diseases needing anti-coagulation treatment were chosen from June 2010 to Feb. 2012, and then randomly divided into control group and observation group (each n=83). The control group was only given aspirin (100 mg, qd) and observation group, rabeprazole enteric capsules (20 mg, qd) besides of aspirin. The gastrointestinal symptoms including epigastric discomfort and pain, heartburn, sour regurgitation, mucosa changes under gastroscope, and gastrointestinal bleeding symptoms including hematemesis and melena were compared between two groups. Results There were 37 cases (44.6%) with gastrointestinal symptoms in observation group and 4 (4.8%) in control group. There were 29 (34.9%) with gastrointestinal mueosa lesions in control group, among which 12 (14.5%) with peptic ulcer, and 6 (7.2%) with gastrointestinal mucosa lesions in observation group, among which only 1 (1.2%) with peptic ulcer. The incidences of gastrointestinal symptoms, gastrointestinal mucosa lesions and peptic ulcer were significantly lower in observation group than those in control group (all P〈0.05). After follow-up for 3 months and 6 months, the incidence of gastrointestinal bleeding symptoms was lower in observation group than those in control group (P〈0.05). Conclusion Rabeprazole enteric capsules can reduce the bleeding risk during treatment of peptic ulcer with low-dose aspirin.
出处 《中国循证心血管医学杂志》 2013年第3期281-282,292,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 雷贝拉唑钠 阿司匹林 溃疡 心血管疾病 Rabeprazole sodium Aspirin Ulcer Cardiovascular diseases
  • 相关文献

参考文献10

二级参考文献31

  • 1Karasawa H, Tani N, Miwa T. The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn, 1988,23 1-8.
  • 2Besancon M, Simon A, Sachs G, et al. Sites of reaction of the gastric H, K-ATPase with extracytoplasmic thiol reagents. J Biol Chem, 1997,272:22438-22446.
  • 3Dekkers CP, Beker JA, Thjodleifsson B, et al. Comparison of rabeprazole 20 rng vs. omeprazole 20 mg in the treatment of active gastric ulcer a European muhicentre study. The European Rabeprazole Study Group. Aliment Pharmacol Ther, 1998, 12: 789-795.
  • 4Fujisaki H, Shibata H, Oketani K, et ai. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Biochem Pharmacol, 1991,42 : 321-328.
  • 5Williams MP, Pounder RE. Review article: the pharmacology of rabeprazole. Aliment Pharmacol Ther, 1999,13 (Suppl 3) : 3-10.
  • 6Sharara AI. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication. Expert Rev Anti Infect Ther, 2005,3: 863-870.
  • 7Langtry HD,Markham A.Rabeprazole:a review of its use in acid-related gastrointestinal dieorder[J].Drugs,1999,58(4):725 -742.
  • 8Humphries TJ,Merritt GJ.Review article:drulg interaction with agents used to treat acid-related diseases[J].Aliment Pharmacol Ther,1999,13(suppl3):18-26.
  • 9中国胃食管反流病共识意见专家组.中国胃食管反流病共识意见(2006·10三亚)[J].中华内科杂志,2007,:170-173.
  • 10Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro- oesophageal reflux disease in primary care. Aliment Pharmacol Ther, 2009, 30 : 1030-1038.

共引文献49

同被引文献112

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部